These independent CME/CE activities are supported by an educational grant from Takeda Oncology.



Clinical Context:
Multiple Myeloma
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Search by

Currently Available

Course Title Curriculum Faculty Release Date
Treatment of a Relapsing High-Risk Multiple Myeloma PatientCase Study (1) 2275.02 III Kumar Oct 2016
Treatment of a Patient with Relapsed/Refractory Multiple Myeloma and No ComorbiditiesCase Study (2) 2275.03 III Bringhen Sep 2016
Role of Proteasome Inhibitor Therapy in a Patient with High-Risk Relapsing Multiple MyelomaCase Study (3) 2275.04 III Shah Jul 2016
Case Study: Role of Immunomodulatory Drug Therapy in a Patient with Refractory Multiple MyelomaCase Study (4) 2275.01 III Anderson Apr 2016
Pembrolizumab Plus Lenalidomide Gets Response in MM: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.50
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Multiple Myeloma: MedPage Today Hallway Buzz Segments from the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.27
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Novel Agent Promising in Pretreated Myeloma: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.48
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Plitidepsin Shows Activity in Multiple Myeloma: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.49
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Extended PFS Seen With Early Myeloma Tx: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.47
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Should Smoldering Multiple Myeloma Get Early Tx?: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.46
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Combo Boosts PFS in Tough-to-Treat Myeloma: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.44
(This activity is hosted on MedPageToday.com.)
III Jun 2016
All Oral Multiple Myeloma Regimen Shows Activity: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.45
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Upfront ASCT Still Wins in Young Myeloma Patients: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.43
(This activity is hosted on MedPageToday.com.)
III Jun 2016
Lenalidomide Maintenance Tx Durable in Multiple Myeloma: MedPage Today's Coverage of the 2016 ASCO (American Society of Clinical Oncology) Annual MeetingMeeting Coverage (MM) 2275.42
(This activity is hosted on MedPageToday.com.)
III Jun 2016
CD38 May Vanish in Relapsed Refractory Myeloma: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.41
(This activity is hosted on MedPageToday.com.)
III May 2016
Upfront Four-Drug Tx Works in Multiple Myeloma: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.40
(This activity is hosted on MedPageToday.com.)
III May 2016
Combination Active in Relapsed/Refractory Myeloma: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.39
(This activity is hosted on MedPageToday.com.)
III Apr 2016
Guideline: In Myeloma, Pay Attention to Kidneys Early: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.38
(This activity is hosted on MedPageToday.com.)
III Mar 2016
No Survival Boost With Three-Drug Tx in Older MM Patients: MedPage Today's Multiple Myeloma Journal InsightMeeting Coverage (MM) 2275.37
(This activity is hosted on MedPageToday.com.)
III Mar 2016
Maintenance Tx in MM: No Advantages With Revlimid: MedPage Today's Multiple Myeloma Journal InsightMeeting Coverage (MM) 2275.36
(This activity is hosted on MedPageToday.com.)
III Mar 2016
Tx Trio Ups PFS in Heavily Pretreated Myeloma: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.35
(This activity is hosted on MedPageToday.com.)
III Feb 2016
Sequential, Alternating Drug Regimens Both Effective in Myeloma: MedPage Today's Multiple Myeloma Journal insightJournal Insights (MM) 2275.34
(This activity is hosted on MedPageToday.com.)
III Feb 2016
Adding Carfilzomib to Myeloma Salvage Boosts Response Rate:MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.33
(This activity is hosted on MedPageToday.com.)
III Jan 2016
Second Cancers Portend 'Dismal Outcome' in Myeloma: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.32 III Jan 2016
Pomalidomide and Ixazomib Pair Up in Refractory Myeloma: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.31
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Filanesib Plus Carfilzomib Active in Myeloma: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.30
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Pomalidomide Safe in Renally-Impaired Myeloma Patients: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.29
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Filanesib 'Promising' in Pretreated Multiple Myeloma: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.28
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Weekly Carfilzomib Effective in Relapsed MM: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.26
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Blockade With Pembrolizumab Combo Shows Anti-MM Activity: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.25
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Combo Tx With Ibrutinib Has Promise in MM: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.23
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Ixazomib Combo Ups Median PFS in Relapsed/Refractory MM: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.24
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Daratumumab Combo Demonstrates Efficacy in MM: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.22
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Anti-BCMA Tx Shows Promise in Multiple Myeloma: MedPage Today's Coverage of the 57th American Society of Hematology (ASH) Annual Meeting & ExpositionMeeting Coverage (MM) 2275.21
(This activity is hosted on MedPageToday.com.)
III Dec 2015
Searching for High-Risk Myeloma Precursors: MedPage Today's Coverage of the 3rd Annual Meeting of the Society of Hematologic Oncology (SOHO)Meeting Coverage (MM) 2275.20
(This activity is hosted on MedPageToday.com.)
III Nov 2015
MEK Inhibitor Falls Flat in Pretreated Multiple Myeloma: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.19
(This activity is hosted on MedPageToday.com.)
III Oct 2015
Female Sex Hormones: No Role in Multiple Myeloma Risk?: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.18
(This activity is hosted on MedPageToday.com.)
III Oct 2015
Myeloma Treatment Options Continue to Emerge: MedPage Today's Coverage of the European Cancer Congress 2015Meeting Coverage (MM) 2275.17
(This activity is hosted on MedPageToday.com.)
III Oct 2015
Potential Myeloma Vaccine Strategy Investigated: MedPage Today's Coverage of the European Cancer Congress 2015Meeting Coverage (MM) 2275.16
(This activity is hosted on MedPageToday.com.)
III Oct 2015
Light Chain Amyloidosis No Systemic Threat: MedPage Today's Coverage of the 3rd Annual Meeting of the Society of Hematologic Oncology (SOHO)Meeting Coverage (MM) 2275.14
(This activity is hosted on MedPageToday.com.)
III Sep 2015
New Combos, Targets Offer Optimism for Myeloma: MedPage Today's Coverage of the 3rd Annual Meeting of the Society of Hematologic Oncology (SOHO)Meeting Coverage (MM) 2275.13
(This activity is hosted on MedPageToday.com.)
III Sep 2015
Multiple Myeloma: Highly Active Combo Effective in Phase I Study: MedPage Today's Multiple Myeloma Journal InsightJournal Insights (MM) 2275.15
(This activity is hosted on MedPageToday.com.)
III Sep 2015
Antibody Research Catches Up in Myeloma: MedPage Today's Coverage of the 3rd Annual Meeting of the Society of Hematologic Oncology (SOHO)Meeting Coverage (MM) 2275.12
(This activity is hosted on MedPageToday.com.)
III Sep 2015
Maintenance Therapy for Myeloma Evolves: MedPage Today's Coverage of the 3rd Annual Meeting of the Society of Hematologic Oncology (SOHO)Meeting Coverage (MM) 2275.11
(This activity is hosted on MedPageToday.com.)
III Sep 2015